Cargando…

Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation

AIM: To study the role of senescent fibroblasts (SFs) and its secretory phenotypes promoting fibrosis and malignancy in oral submucous fibrosis (OSMF). MATERIAL METHODS: A total of 20 cases of OSMF and 20 normal oral mucosal tissues were taken for the study. The tissue sections were stained for IHC-...

Descripción completa

Detalles Bibliográficos
Autores principales: Karnam, Shyamala, Girish, H C, Nayak, Vaidhehi N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364628/
https://www.ncbi.nlm.nih.gov/pubmed/35968184
http://dx.doi.org/10.4103/jomfp.jomfp_115_21
_version_ 1784765183427608576
author Karnam, Shyamala
Girish, H C
Nayak, Vaidhehi N.
author_facet Karnam, Shyamala
Girish, H C
Nayak, Vaidhehi N.
author_sort Karnam, Shyamala
collection PubMed
description AIM: To study the role of senescent fibroblasts (SFs) and its secretory phenotypes promoting fibrosis and malignancy in oral submucous fibrosis (OSMF). MATERIAL METHODS: A total of 20 cases of OSMF and 20 normal oral mucosal tissues were taken for the study. The tissue sections were stained for IHC-immunohistochemistry with senescent cell marker p(16INK4a). The supernatant solution of the transport medium was studied for leached out senescent associated secretory proteins (SASP): matrix metalloproteinases 9 (MMP9), interleukins 6 (IL6), vascular endothelial growth factor (VEGF). Tissues were studied for malignant transformation with p53 and Ki67. Fibrosis in the OSMF was tested with lysyloxidase (LOX). The Statistical Package for the Social Sciences (SSPS) statistical software was used to analyze the data. RESULTS: IHC staining for p(16INK4a)showed positivity in the connective tissue of OSMF cases which was statistically significant. Antibody assay using enzyme-linked immunosorbent assay (ELISA) showed elevated levels of secretoproteins IL6, MMP9, VEGF in OSMF cases. LOX enzyme levels were also significantly increased in OSMF cases. Proliferative markers Ki67 and p53 were positive in IHC staining in the epithelium of OSMF. CONCLUSION: This study confirms the presence of SF and its secreto phenotypes in OSMF and showed increased LOX expression which is implicated in fibrosis. These findings suggest that SF may contribute to fibrosis in OSMF. The study also confirms the malignant transformation of the overlying epithelium as shown by p53 and Ki67 positivity.
format Online
Article
Text
id pubmed-9364628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-93646282022-08-11 Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation Karnam, Shyamala Girish, H C Nayak, Vaidhehi N. J Oral Maxillofac Pathol Original Article AIM: To study the role of senescent fibroblasts (SFs) and its secretory phenotypes promoting fibrosis and malignancy in oral submucous fibrosis (OSMF). MATERIAL METHODS: A total of 20 cases of OSMF and 20 normal oral mucosal tissues were taken for the study. The tissue sections were stained for IHC-immunohistochemistry with senescent cell marker p(16INK4a). The supernatant solution of the transport medium was studied for leached out senescent associated secretory proteins (SASP): matrix metalloproteinases 9 (MMP9), interleukins 6 (IL6), vascular endothelial growth factor (VEGF). Tissues were studied for malignant transformation with p53 and Ki67. Fibrosis in the OSMF was tested with lysyloxidase (LOX). The Statistical Package for the Social Sciences (SSPS) statistical software was used to analyze the data. RESULTS: IHC staining for p(16INK4a)showed positivity in the connective tissue of OSMF cases which was statistically significant. Antibody assay using enzyme-linked immunosorbent assay (ELISA) showed elevated levels of secretoproteins IL6, MMP9, VEGF in OSMF cases. LOX enzyme levels were also significantly increased in OSMF cases. Proliferative markers Ki67 and p53 were positive in IHC staining in the epithelium of OSMF. CONCLUSION: This study confirms the presence of SF and its secreto phenotypes in OSMF and showed increased LOX expression which is implicated in fibrosis. These findings suggest that SF may contribute to fibrosis in OSMF. The study also confirms the malignant transformation of the overlying epithelium as shown by p53 and Ki67 positivity. Wolters Kluwer - Medknow 2022 2022-06-28 /pmc/articles/PMC9364628/ /pubmed/35968184 http://dx.doi.org/10.4103/jomfp.jomfp_115_21 Text en Copyright: © 2022 Journal of Oral and Maxillofacial Pathology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Karnam, Shyamala
Girish, H C
Nayak, Vaidhehi N.
Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
title Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
title_full Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
title_fullStr Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
title_full_unstemmed Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
title_short Senescent Fibroblast in Oral Submucous Fibrosis Aids in Disease Progression and Malignant Transformation
title_sort senescent fibroblast in oral submucous fibrosis aids in disease progression and malignant transformation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364628/
https://www.ncbi.nlm.nih.gov/pubmed/35968184
http://dx.doi.org/10.4103/jomfp.jomfp_115_21
work_keys_str_mv AT karnamshyamala senescentfibroblastinoralsubmucousfibrosisaidsindiseaseprogressionandmalignanttransformation
AT girishhc senescentfibroblastinoralsubmucousfibrosisaidsindiseaseprogressionandmalignanttransformation
AT nayakvaidhehin senescentfibroblastinoralsubmucousfibrosisaidsindiseaseprogressionandmalignanttransformation